Researchers at the Institute of Science Tokyo, working with colleagues at Teikyo University and the University of California Irvine, have traced a molecular pathway connecting a high-fat diet to impaired brain function in mice. Their paper, published in Molecular Psychiatry, focuses on a nuclear protein called PQBP1, which helps regulate alternative RNA splicing, the process that lets one gene produce different RNA transcripts and protein versions.
After mice were fed a high-fat diet, the team found reduced PQBP1 levels in the cerebral cortex, a region involved in cognitive functions. The authors link this drop to suppressed PPARγ-mediated transcription of the PQBP1 gene and point to insulin-related signaling as a possible upstream cause. Comparing mice on a high-fat diet for one or six weeks with mice lacking PQBP1 in neurons, the researchers identified shared splicing changes in several genes involved in synaptic function.
Those altered splicing patterns were associated with abnormal synaptic structure and function, along with cognitive impairment. The researchers describe PQBP1-dependent splicing as a key link between high-fat diet and impaired neuronal communication.
The effects appeared reversible in these experiments. Pioglitazone, a diabetes drug that activates PPARγ, restored PQBP1 levels, corrected splicing in key synapse genes and improved synaptic and cognitive outcomes in high-fat-fed mice. Gene therapy to restore PQBP1 also rescued synaptic and cognitive deficits, and restoring specific downstream genes produced benefits as well.
Lead author Hitoshi Okazawa said the work highlights a potential new direction for interventions targeting cognitive dysfunction, while noting that further research is needed to translate these findings into therapies. Because the work was done in mice, it shows a mechanism and a possible target rather than an established treatment for people.